How to buy evantumumab in the country? What formal purchasing channels are there?
Amivantumab (amivantamab) has just been launched in China, but due to its short time on the market, domestic patients may currently encounter difficulties in purchasing it. The main reason is that the drug is not yet widely available and may not be fully available in all hospitals or pharmacies. Therefore, patients need to pay special attention to the supply of medicines when purchasing. It is recommended that patients first check with their local hospital pharmacy to see if the drug is in stock and to understand the drug purchase process and price.
If patients cannot purchase evantumumab directly in China, they may consider purchasing it through overseas versions. Evantumumab has been launched in Hong Kong, China, and as an original drug, its quality and efficacy are guaranteed. According to our understanding, the price of evantumumab in Hong Kong is about NT$10,000. Patients can contact regular pharmacies or drug sales channels in Hong Kong to purchase the drug through legal channels to ensure the authenticity and quality of the drug.
In addition to pharmacies in Hong Kong, patients can also purchase the drug through some professional drug import agents. Many international drug agents provide services for importing drugs from Hong Kong or other countries to help patients successfully obtain the treatment drugs they need. When choosing an agent, patients should make sure to choose an agency with a good reputation and that complies with relevant laws and regulations to avoid purchasing counterfeit or expired drugs.
It should be noted that when using overseas channels to purchase drugs, patients should ensure that all drug purchase procedures are legal and compliant, and understand the relevant drug transportation, tariffs and other costs, so as not to affect the timely use of the drugs. In addition, patients should consult their doctor about the dosage and treatment plan when purchasing drugs to ensure the safety and effectiveness of the treatment.
Reference materials:https://www.rybrevant.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)